FDA recall Z-0601-2019

Tosoh Bioscience Inc · Class III · device

Product

Hemoglobin A1c Control, Part no. 220232 for use as quality control material to monitor the precision of laboratory testing procedures for HbA1c quantitation.

Reason for recall

Tosoh Bioscience has become aware of potential degradation of HbA1c control lot # 7055 before the 60-days product stability claim. If degradation of these controls occurs, P00 peaks may be seen and the % HbA1c control values may drift higher than the assigned range. This may result in delays when performing routine instrument quality control. If this issue occurs, there may be a delay in testing and reporting patient test results. Tosoh has received two (2) complaints related to this issue with no serious injuries reported.

Distribution

Distributed nationwide. Foreign distribution to Canada.

Key facts

Status
Terminated
Initiation date
2018-10-05
Report date
2018-12-19
Termination date
2020-06-16
Voluntary/Mandated
Voluntary: Firm initiated
Location
Grove City, OH, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0601-2019